Low Hepatic Lipase Activity Is a Novel Risk Factor for Coronary Artery Disease
Author(s) -
Klaus A. Dugi,
Karin Brandauer,
Nikolaus Schmidt,
Barbara Nau,
Jochen G. Schneider,
Stefani Mentz,
Tanja Keiper,
Juergen R. Schaefer,
Christoph Meißner,
H Kather,
Malte L. Bahner,
W. Fiehn,
Joerg Kreuzer
Publication year - 2001
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/hc5001.100795
Subject(s) - medicine , coronary artery disease , confounding , hepatic lipase , gastroenterology , cardiology , endocrinology , cholesterol , lipoprotein
The crucial function of hepatic lipase (HL) in lipid metabolism has been well established, but the relationship between HL activity and coronary artery disease (CAD) is disputed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom